Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2010 2
2011 2
2012 4
2013 2
2014 1
2015 2
2016 3
2017 4
2019 3
2020 9
2021 10
2022 9
2023 6
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

56 results

Results by year

Filters applied: . Clear all
Page 1
Machine Learning to Identify Critical Biomarker Profiles in New SARS-CoV-2 Variants.
Schatz C, Knabl L, Lee HK, Seeboeck R, von Laer D, Lafon E, Borena W, Mangge H, Prüller F, Qerimi A, Wilflingseder D, Posch W, Haybaeck J. Schatz C, et al. Among authors: borena w. Microorganisms. 2024 Apr 15;12(4):798. doi: 10.3390/microorganisms12040798. Microorganisms. 2024. PMID: 38674742 Free PMC article.
Outcome 10 years after Shiga toxin-producing E. coli (STEC)-associated hemolytic uremic syndrome: importance of long-term follow-up.
Rosales A, Kuppelwieser S, Giner T, Hofer J, Riedl Khursigara M, Orth-Höller D, Borena W, Cortina G, Jungraithmayr T, Würzner R; German-Austrian H. U. S.-Study Group. Rosales A, et al. Among authors: borena w. Pediatr Nephrol. 2024 Apr 9. doi: 10.1007/s00467-024-06355-z. Online ahead of print. Pediatr Nephrol. 2024. PMID: 38589699
Retained avidity despite reduced cross-binding and cross-neutralizing antibody levels to Omicron after SARS-COV-2 wild-type infection or mRNA double vaccination.
Harthaller T, Falkensammer B, Bante D, Huber M, Schmitt M, Benainouna H, Rössler A, Fleischer V, von Laer D, Kimpel J, Würzner R, Borena W. Harthaller T, et al. Among authors: borena w. Front Immunol. 2023 Jul 21;14:1196988. doi: 10.3389/fimmu.2023.1196988. eCollection 2023. Front Immunol. 2023. PMID: 37545492 Free PMC article.
Immune response after two doses of the BNT162b2 COVID-19 vaccine and risk of SARS-CoV-2 breakthrough infection in Tyrol, Austria: an open-label, observational phase 4 trial.
Seekircher L, Bánki Z, Kimpel J, Rössler A, Schäfer H, Falkensammer B, Bante D, Forer L, Schönherr S; Shieldvacc-2 Study Group; Harthaller T, Sacher M, Ower C, Tschiderer L, Ulmer H, Krammer F, von Laer D, Borena W, Willeit P. Seekircher L, et al. Among authors: borena w. Lancet Microbe. 2023 Aug;4(8):e612-e621. doi: 10.1016/S2666-5247(23)00107-6. Epub 2023 Jun 21. Lancet Microbe. 2023. PMID: 37354911 Free PMC article. Clinical Trial.
Viral infection in chronic otitis media with effusion in children.
Runge A, Straif S, Banki Z, Borena W, Muellauer B, Brunner J, Gottfried T, Schmutzhard J, Dudas J, Risslegger B, Randhawa A, Lass-Flörl C, von Laer D, Riechelmann H. Runge A, et al. Among authors: borena w. Front Pediatr. 2023 May 10;11:1124567. doi: 10.3389/fped.2023.1124567. eCollection 2023. Front Pediatr. 2023. PMID: 37234860 Free PMC article.
56 results